title: Enhancing effect of electric stimulation on cytotoxicity of anticancer agents against rat and human glioma cells.
abstract: Electropermeabilization, or electroporation, has been used to deliver genes or drugs into the cytoplasm through micropores in the cell membrane caused by electric stimulation. The cytotoxic effect of a combination of anticancer agents with electric stimulation on rat C6 and human T98G glioma cells was examined in vitro. Electric pulses of 100 microsec square waves (eight cycles at 1 Hz) at various electric fields were delivered to C6 or T98G glioma cell suspensions in combination with several anticancer agents. Cell growth was evaluated 48-72 h after treatment. Measurement of cell lysis by electric stimulation was used to assess the optimum field strength for electroporation. Electric stimulation enhanced significantly the cytotoxicity of bleomycin to both C6 and T98G cells by more than 1000-fold using an electric field of 1750 V/cm for C6 cells and 1000 V/cm for T98G cells. The enhancement disappeared when bleomycin concentration was reduced to 100 pg/ml. The cytotoxicity of carboplatin was weakly but significantly enhanced by electric stimulation when a high dose of carboplatin was used. However, there was no enhancement of the cytotoxicity of nimustine hydrochloride (ACNU), etoposide, and vincristine. These results indicate that the combination of bleomycin and electroporation is the most potent candidate for electrochemotherapy in vivo.
authors.affiliation: Department of Neurosurgery, Yamanashi Medical University, Yamanashi, Japan. tohruh@swallow.res.yamanashi-med.ac.jp
authors.forename: T
authors.initials: T
authors.lastname: Horikoshi
authors.forename: H
authors.initials: H
authors.lastname: Naganuma
authors.forename: Y
authors.initials: Y
authors.lastname: Ohashi
authors.forename: T
authors.initials: T
authors.lastname: Ueno
authors.forename: H
authors.initials: H
authors.lastname: Nukui
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001761:Bleomycin / Q000494:pharmacology; D016190:Carboplatin / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D004558:Electric Stimulation; D005047:Etoposide / Q000494:pharmacology; D005910:Glioma / Q000473:pathology*; D006801:Humans; D015376:Nimustine / Q000494:pharmacology; D051381:Rats; D014407:Tumor Cells, Cultured; D014750:Vincristine / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D015376:Nimustine; D001761:Bleomycin; D014750:Vincristine; D005047:Etoposide; D016190:Carboplatin